The condition 'gargoylism' has been known for about 60 years, the first detailed description being given by Hunter in 1917 . Early histological studies showed vacuolated cells in many tissues, and in the belief that these were caused by fat dissolving out during processing, the term lipochondrodystrophy came into use (Washington, 1966) . Then glycogen was thought to be involved in the disorder (de Lange, Gerlings, de Kleyn, and Lettinga, 1944) and only 11 years ago it was realized that glycosaminoglycans were primarily involved in the disease (Dorfman and Lorincz, 1957) . Since then, studies of the urinary glycosaminoglycans in gargoylism, together with careful clinical and genetic documentation, has led to the recognition of six distinct entities within the group, which McKusick (1966) has called the Hurler, Hunter, Sanfilippo, Morquio, Scheie, and Maroteaux-Lamy syndromes.
Though many of the techniques used in the isolation and characterization of glycosaminoglycans cannot easily be employed in hospital Received for publication 22 May 1968. laboratories, several simple tests have emerged for the detection of increased urinary glycosaminoglycan excretion (Berry and Spinanger, 1960;  Denny and Dutton, 1962; Segni, Romano, and Tortorolo, 1964; Manley and Hawksworth, 1966) . It has also been shown that simple cellulose acetate electrophoresis of urinary concentrates will differentiate between at least two types of gargoylism (Manley and Hawksworth, 1966) . This paper presents a laboratory investigation of urinary glycosaminoglycans in 28 cases of gargoylism, in the light of current clinical classification.
MATERIAL AND METHODS
MATERIAL Twenty-eight cases of gargoylism form the basis of this study. A proforma listing relevant clinical features was completed by the clinician in charge of each case, and this data enabled each case to be assigned to one of the six mucopolysaccharidoses of McKusick. Urine was collected over a period of 24 hours, and preserved with merthiolate. When immediate analysis was impossible, the samples were stored at -20°C. 67 ROUTINE METHODS The CPC turbidity, CPC-precipitable uronic acid level, and uronic acid/creatinine ratio were determined as described previously (Manley, Severn, and Hawksworth, 1968) .
CONCENTRATION OF URINE FOR ELECTROPHORESIS This
was carried out as described by Manley and Hawksworth (1966) , with some modifications. Centrifuged urine (50 ml) was concentrated. A vacuum was applied to the Woulff's bottle by gas-ballast pump, and a regulatory valve, fitted with a vacuum gauge, was interposed between the pump and the Woulff's bottle so that the suction applied could be set exactly at -710 mm Hg. The water in the Woulff's bottle was mixed by magnetic stirring. Concentration was carried out for 24 hours. The application of a controlled vacuum for a fixed time was found to favour reproducibility, for in this way the inevitable loss of glycosaminoglycans through the dialysis sac was standardized. The residue remaining in the sac after 24 hours was transferred quantitatively to AutoAnalyzer pots, and dried over silica gel.
SEPARATION OF GLYCOSAMINOGLYCANS BY ELECTRO-
PHORESIS The dried urine concentrates were dissolved in 0 5 ml water, and samples equivalent to 5 to 20 l&g uronic acid were applied to cellulose acetate strips as described previously (Manley and Hawksworth, 1966) . After electrophoresis in Michaelis's veronal acetate buffer, pH 9-2, at 20 v/cm for 80 minutes in a constant temperature room at 20°C, the strips were stained for 30 minutes in a solution of 1 % alcian blue in 2 % acetic acid. After staining, the strips were transferred to a slowly rotating frame in a running-water bath, to wash for 30 minutes. Quantitation of the alcian blue-positive fractions was carried out in a Joyce Chromoscan as described previously.
DIGESTION WITH TESTICULAR HYALURONIDASE This was carried out as described in the previous paper (Manley et al, 1968) , the glycosaminoglycans remaining in the digests and saline controls being separated by electrophoresis.
SEPARATION OF GLYCOSAMINOGLYCANS BY COLUMN
CHROMATOGRAPHY Urine concentrates and urinary glycosaminoglycans prepared by CPC precipitation, containing an equivalent of 600 ,ug of uronic acid, were applied to a 1 x 40 cm column of Dowex 1 Cl x 2-400, and eluted with an increasing NaCl gradient as described in the previous paper. The NaCl molarity of the column effluent was recorded automatically from the change in conductivity between two platinum-black electrodes set at either side of the column outlet. A small capillary placed between the electrodes conveyed the effluent to an AutoAnalyzer which performed continuous flow uronic acid analysis of the column effluent, employing an AutoAnalyzer adaptation of Bitter and Muir's (1962) modification of the carbazole method. Thus the NaCl and uronic acid concentration of the column effluent were recorded automatically.
HEXOSAMINE ASSAY Aliquots of urine concentrates, equivalent to 40 ,ug uronic acid, were transferred to Pyrex tubes, and dried in vacuo over silica gel. Hydrochloric acid (0 5 ml), twice distilled and adjusted to 4 N, was added to each. The tubes were filled with nitrogen and sealed. Hydrolysis was carried out at 100°C for eight hours. HCI was removed in vacuo over KOH. Water (10 ml) was added and the hexosamine concentration determined by Boas' (1953) modification of the Elson-Morgan reaction. For the column separation of glucosamine and galactosamine, an aliquot of the urine concentrate equivalent to 800 pg of uronic acid was hydrolysed in the same way.
COLUMN CHROMATOGRAPHIC SEPARATION OF GLUCOSAMINE
AND GALACTOSAMINE Hydrolysates of urinary concentrates equivalent to 800 pLg of uronic acid were applied to a 1 x 40 cm. column of Dowex H+ x 8-400 and eluted with 0-3 M HCI at 6 ml/hr as described by Gardell (1953) . Effluent fractions (1-0 ml) were collected in AutoAnalyzer pots by an LKB Radi Rac fraction collector. The hexosamine content of each fraction was determined by an AutoAnalyzer adaptation of the Elson-Morgan reaction, using 0-3 M trisodium phosphate instead of sodium carbonate for the acetylation-condensation procedure.
GEL-FILTRATION COLUMN CHROMATOGRAPHY OF GLYCO-SAMINOGLYCANS Urinary glycosaminoglycans prepared by CPC precipitation, equivalent to 200 pg uronic acid, were dissolved in 0 5 M NaCl (1-0 ml) and applied to a 1 x 100 cm column of Sephadex G 50 (fine) in 0-5 M NaCI. The column was eluted with 0 5 M NaCl at 6 ml/hr, and the effluent collected in fractions of 1I0 ml in AutoAnalyzer pots. The uronic acid content of each fraction was determined by the AutoAnalyzer adaptation of the carbazole method of Bitter and Muir (1962) . Standard vascular chondroitin-6-sulphate, Mw. 48,000, and tetrasaccharides produced by the action of testicular hyaluronidase on chondroitin-6-sulphate were prepared as described by Mullinger, Lloyd, and Manley (1969) .
ULTRACENTRIFUGAL SEDIMENTATION OF GLYCOSAMINO-GLYCANS Urinary glycosaminoglycans were prepared as their sodium salts by CPC and alcohol precipitation. They were dissolved in 0 15 M NaCl to give a uronic acid concentration of 2-0 mg/ml. Sedimentation velocity runs were carried out at 59,780 rev/min using Schlieren optics in a Beckman model E analytical ultracentrifuge. TERMINOLOGY Gargoylism is used as an umbrella term to include all the mucopolysaccharidoses. The suggestions of Jeanloz (1960) are followed for the nomenclature of mucopolysaccharides.
RESULTS
The age, sex, and relevant clinical features of the cases studied are shown in Table I Electrophoresis of the urine concentrates yielded the three major alcian-blue-positive fractions observed in normal urines (Manley et al, 1968) but in other respects the patterns differed considerably from normal ( Fig. 1) . One difference was quantitative. A volume equivalent to only 0-1 to 0-8 ml of urine was necessary for optimal staining intensity in this study. Another difference was the proportion of glycoprotein relative to the sulphated glycosaminoglycans; one or other of the glycosaminoglycan fractions was considerably increased, so that the relative proportion of glycoprotein was greatly reduced. A group.bmj.com on November 7, 2017 -Published by http://jcp.bmj.com/ Downloaded from affliction but severe mental retardation. These cases tended to have lower uronic acid/creatinine ratios, in the range 40 to 135.
These two major groups were easily recognizable, but a number of cases showed patterns that did not fall exactly into either group. A third group in which there was a major increase in the chondroitin sulphate fraction, though less marked than in the true Hurler cases, showed in addition a minor increase in the heparan sulphate fraction. These cases showed similar clinical features to the Hurler syndrome, though in every case less severe, and corneal opacities did not occur. All cases were male, and they were thought to correspond clinically to the Hunter syndrome. The uronic acid/creatinine ratio was generally rather lower than in cases of the Hurler syndrome, in the range 65 to 180.
A fourth type, showing a moderate increase in the chondroitin sulphate fraction, and if anything a decrease in the heparan sulphate fraction, showed clinical features corresponding to the Scheie syndrome, the major affliction being the development of corneal opacities. These cases showed only a moderate increase in the uronic acid/creatinine ratio, within the range 30 to 50. The four types of electrophoretic pattern are illustrated in Figure 1 .
A fifth electrophoretic pattern, characteristic of the Morquio syndrome, was expected, but results with cases labelled 'the Morquio syndrome' on clinical grounds were disappointing. Only one offour cases examined showed an increased glycosaminoglycan excretion, and no characteristic electrophoretic pattern was found.
Electrophoresis of hyaluronidase-treated samples showed that in cases exhibiting a major increase in the chondroitin sulphate fraction, the fraction was unaffected by hyaluronidase. In this respect the fraction differed considerably from that found in normal urine. In cases showing a major increase in the heparan sulphate fraction, this fraction was unaffected by hyaluronidase, as is the heparan sulphate fraction of normal urine. The chondroitin sulphate fraction in these cases was reduced by about 80% after hyaluronidase digestion.
Column chromatography of urine concentrates, and of glycosaminoglycans isolated by CPC precipitation, showed uronic acid elution patterns that corresponded only roughly with the electrophoretic patterns. In cases of the Hurler syndrome, the major uronic acid-containing fraction left the column in 1-5 to 1-7 M NaCl (Fig. 2e) , as expected for chondroitin sulphate; and in cases of the Sanfilippo syndrome, the major fraction left the column in 0-6 to 1-3 M NaCl (Fig. 2f) (ratio 192: 1) .
Column chromatographic separation of the aminosugars derived from the urine concentrates by hydrolysis showed two major fractions in each case, corresponding to glucosamine hydrochloride and galactosamine hydrochloride. Cases of the Hurler syndrome showed a major increase in the galactosamine fraction, but also some increase in the glucosamine fraction (Fig. 2g) . The glucosamine :galactosamine ratio was 1:1-8 after correcting for the lower colour yield of galactosamine in the ElsonMorgan reaction. Cases of the Sanfilippo syndrome showed a major increase in the glucosamine fraction (Fig. 2h) , giving a glucosamine :galactosamine ratio of 1:0-6. Molecular weight examinations were carried out on the CPC-precipitated glycosaminoglycans from cases of the Hurler and Sanfilippo syndromes, but because of the difficulties involved in the physical examination of these highly charged polyanions, only approximate, comparative measurements were made. 'Molecular sieving' chromatography on Sephadex G 50 showed that none of the molecules were totally excluded from the gel, and although the major peak emerged close to the void volume, uronic acid-containing molecules continued to be eluted until the total volume was approached. Arterial chondroitin-6-sulphate of molecular weight 48,000 was totally excluded, being eluted with the void volume; tetrasaccharides derived from the testicular hyaluronidase-digestion of arterial chondroitin-6-sulphate were eluted close to the total volume, and a standard sample of glucuronic acid (British Drug Houses Ltd) was eluted with the total volume.
Ultracentrifugal sedimentation of the urinary glycosaminoglycans showed broad and slowlysedimenting Schlieren peaks in both the Hurler and Sanfilippo syndromes. The peaks were slightly skew, due to extension of the trailing edge. At the concentration employed, sedimentation rates were 1-0 for the heparan sulphate excreted in the Sanfilippo syndrome and 1-1 for the chondroitin sulphate excreted in the Hurler syndrome.
DISCUSSION
It is clear that the urinary glycosaminoglycans in gargoylism do not present a stiaightforward problem and sometimes exhibit atypical behaviour in analytical procedures. However, the excretion of glycosaminoglycans in most cases of gargoylism is so different from normal that the problem of laboratory diagnosis is straightforward.
The CPC turbidity test is a simple and reliable screening procedure, clearly differentiating gargoyles from the great majority of non-gargoyles, and false negative results have not been encountered. The previous paper (Manley et a!, 1968) emphasized the danger of the normally high glycosaminoglycan excretion in infancy, and the presence of excessive amounts of glycoprotein at all ages, producing an increase in the CPC turbidity, but these factors cannot lead to a false diagnosis of gargoylism if the uronic acid/creatinine ratio and electrophoretic pattern are determined in all cases with a CPC turbidity above 0 5.
The CPC turbidity is an unreliable guide to the total glycosaminoglycan excretion when this is excessively high. One reason for this is that if the urine glycosaminoglycan concentration is excessive, not all of it is precipitated by the amount of CPC normally added.
A serious source of error is the presence of bacteria in the urine sample. Many bacteria can elaborate enzymes that degrade glycosaminoglycans, and unless the concentration of merthiolate in the urine is at least 1:10,000 (w/v) bacterial contamination can completely alter the glycosaminoglycans present. The degradative effect of endogenous testicular hyaluronidase in the urine sample must also be borne in mind when dealing with adult males.
The CPC-precipitable uronic acid/creatinine ratio is the most reliable method of detecting excessive glycosaminoglycan excretion that is suitable for routine use, and clearly differentiates cases of gargoylism (with the exception of the Morquio syndrome) from other disorders. The excessively high concentration of glycosaminoglycans present in the urine of some casesofthe Hurlersyndrome can be a source of slight error in this test, and after sedimenting the CPC-glycosaminoglycan complex in the centrifuge, it is advisable to add more CPC to the clear supernatant to ensure that all the glycosaminoglycans have been precipitated.
The electrophoretic pattern of glycosaminoglycans differentiates clearly between the two major forms of gargoylism: the Hurler and the Sanfilippo syndromes. These two distinct patterns were thought, in an earlier publication (Manley and Hawksworth, 1966) , to differentiate between the autosomal Hurler syndrome and the sex-linked Hunter syndrome, mainly on the basis of evidence presented by Terry and Linker (1964) The Scheie syndrome presents a clear electrophoretic pattern, with a sharp increase in the testicular hyaluronidase-resistant chondroitin sulphate fraction, and no increase, or even a decrease, in the heparan sulphate fraction. There is only a modest increase in the uronic acid/creatinine ratio. The disappointing results obtained with these techniques from cases diagnosed clinically as the Morquio syndrome are puzzling. The clinical group 'Morquio's syndrome' may be heterogeneous, including some conditions that do not have a disorder of glycosaminoglycans as the basic defect. The heterogeneity of this clinical group has also been suggested by skin fibroblast cultures (Danes and Bearn, 1967; Magrini, Fraccaro, Tiepolo, Scappaticci, Lenzi, and Perona, 1967) . Techniques based on uronic acid assay will not detect an increased keratan sulphate excretion. Reliance on the total hexose or hexosamine/uronic acid ratio of urinary concentrates, or CPC precipitates, for the diagnosis of keratansulphaturia may be misleading, for increased glycoprotein excretion will also increase this ratio. The presence of excessive amounts of keratan sulphate in the urine of patients suffering from the 'Morquio-Ullrich syndrome' seems established (Zellweger, Ponseti, Pedrini, Stamler, and Von Noorden, 1961; Robins, Stevens, and Linker, 1963; Maroteaux and Lamy, 1965) and accepted as part of the Morquio syndrome by McKusick (1966) , but it seems that further studies are necessary before a simple method for the diagnosis of the Morquio syndrome can be introduced to hospital laboratories.
The discrepancy between column fractionation and electrophoretic separation of urinary glycosaminoglycans in the Hurler syndrome is interesting. Although electrophoresis shows that more than 90 % of the urinary glycosaminoglycan has an electrophoretic migration identical with that of chondroitin sulphate, a proportion of the uronic acid-containing material is eluted from a column of Dowex 1-Cl at a sodium chloride concentration of between 0-7 and 1-3 M, suggesting the presence of increased amounts of heparan sulphate. The measurement of glucosamine and galactosamine in acid hydrolysates of urine concentrates shows that the concentration of glucosamine is increased in addition to galactosamine, again suggesting that heparan sulphate is increased in addition to chondroitin sulphate.
An increased urinary excretion of heparan and chondroitin sulphates in cases of the Hurler syndrome is well supported (Meyer, Hoffman, Linker, Grumbach, and Sampson, 1959; Berggard and Beam, 1965; Teller, 1967) but the electrophoretic technique used in this study shows that in fresh, uncontaminated urine, about 90 % of the glycosaminoglycans excreted have a mobility corresponding with chondroitin sulphate. One explanation of this discrepancy is that an oversulphated heparan sulphate is excreted in cases of the Hurler syndrome, and this accompanies chondroitin sulphate on cellulose acetate electrophoresis, where net molecular charge is the overwhelming criterion for fractionation. Another possibility is that hybrid molecules are produced in the Hurler syndrome, with glucosamine being built into the chondroitin sulphate chain. A third possibility is that glycosaminoglycan fragments of low molecular weight may behave atypically on ion-exchange columns, being eluted at a lower salt concentration than expected. Cellulose acetate electrophoresis has the advantage of being relatively free from molecular weight effects.
The two heparan sulphate peaks in column chromatograms from cases of the Sanfilippo syndrome supports the finding of two electrophoretic fractions of heparan sulphate (Manley and Hawksworth, 1966) . Knecht and Dorfman (1965) Gel filtration of the glycosaminoglycans excreted in urine in the Hurler syndrome gives an illustration of its molecular weight polydispersity (Fig. 3) in this series having already died at the age of 6 and 11 years respectively. Cases of the Hunter syndrome with lower uronic acid/creatinine ratios were less severely affected generally. Cases of the Sanfilippo syndrome with high uronic acid/creatinine ratios showed relatively severe somatic affliction, though mental retardation was predominant, and such cases (when male) were often diagnosed clinically as the Hunter syndrome. Clinically diagnosed cases of the Hunter syndrome were found, on examination of the urinary glycosaminoglycans, to be divided between the 'chondroitin sulphate excreting type' with lower uronic acid/creatinine ratios than cases of the true Hurler syndrome, and the 'heparan sulphate excreting type' with higher uronic acid/ creatinine ratios than cases diagnosed as of the Sanfilippo syndrome.
Without the genetic evidence, the biochemical evidence would suggest that the Hunter syndrome did not exist as a separate entity, being an artefact of the overlapping region between mild cases of the Hurler syndrome and severe cases of the Sanfilippo syndrome.
The observation that vitamin C increases the synthesis of glycosaminoglycans by skin fibroblasts (Schafer, Sullivan, Svejcar, Kofoed, and Robertson, 1966) whereas retinol reduces it (Danes and Beam, 1966b ) offers a possible approach to therapy, though the basic defect is unlikely to be modified in this way.
The most important problem-the nature of the basic defect-remains unsolved. In simplest terms, the defect must be either an increased synthesis, or a decreased degradation, of glycosaminoglycans. All the disorders in this group show a recessive pattern of inheritance, and recessive disorders are usually due to enzyme deficiencies (McKusick, 1966) .
There are similarities between the group of disorders considered here, and the lipoidoses. There is evidence for a deficiency of ,B-glucosidase activity in Gaucher's disease (Brady, Kanfer, and Shapiro, 1965) and of sulphatase activity in metachromatic leucodystrophy (Austin, McAfee, Armstrong, O'Rourke, Shearer, and Bachhawat, 1964 Fratantoni, Hall, and Neufeld (1968) strongly support this.
Urinary excretion ofglycosaminoglycans in the various forms ofgargoylism synthesis of glycosaminoglycans that are difficult to degrade.
The alternative hypothesis concerns uncointrolled synthesis of glycosaminoglycans, and the work of Matalon and Dorfman (1966) favours this possibility. Such rogue syntheses are uncommon in genetic disorders, being more characteristic of neoplastic processes such as myelomatosis. However, some features of gargoylism favour this possibility. Dorfman (1964) suggested that the defect in Hurler's syndrome concerns the linkage of glycosaminoglycans to protein. This might result in a breakdown of feedback inhibition from the proteinpolysaccharide end product. An enzyme defect could also be incorporated into this hypothesis. If the defect were remote from the active site of the enzyme, instead involving a region sensitive to feedback inhibition, the result would be uncontrolled enzyme activity. An inherited defect of an allosteric inhibitor site in an enzyme concerned with glycosaminoglycan synthesis, or the failure of a repressor gene, would be compatible with the biochemical observations and acceptable to the geneticists.
The discovery that the biochemical phenotype persists in fibroblasts cultured from the skin of patients suffering from the Hurler syndrome (Danes and Bearn, 1966a) offers the opportunity of testing each hypothesis in controlled laboratory conditions, and it should not be long before the nature of the basic defect is revealed.
